COPD

The AJMC® COPD compendium is a comprehensive resource for clinical news and expert insights for chronic obstructive pulmonary disease.

Latest News

Man holding a cigarette | Image Credit: Nopphon - stock.adobe.com
Rurality, Long Travel Times Limit Access to Tobacco Treatment for Patients With COPD Who Smoke

August 30th 2025

Patients with chronic obstructive pulmonary disease (COPD) who smoke were less likely to receive tobacco dependence treatment (TDT) if they lived in rural areas or had longer travel times to care, highlighting persistent geographic disparities in access.

Man having asthma attack on couch | Image credit: Pixel-Shot – stock.adobe.com
Solrikitug Shows Promise as Next-Generation Anti-TSLP Therapy in Asthma, COPD

June 25th 2025

COPD graphic | Image Credit: Maks_Lab - stock.adobe.com
Systemic Immune Response Index Identified as Independent Risk Factor for COPD

March 23rd 2025

sleeping baby in father's arms | Image Credit: BazziBa - stock.adobe.com
Low Birth Weight Linked to Increased COPD Risk

December 30th 2024

TOP 5 COPD articles of 2024 | Image Credit: Venngage
Top 5 Most-Read COPD Content of 2024

December 26th 2024

Type 2 Inflammation: A Common Theme Among Several Chronic Diseases

Learn about the multifaceted aspects of type 2 inflammatory diseases, including impact on quality of life; the role of biomarkers in diagnosis and treatment selection; and unmet needs in clinical management.

Learn about the multifaceted aspects of type 2 inflammatory diseases, including impact on quality of life; the role of biomarkers in diagnosis and treatment selection; and unmet needs in clinical management.
Continuing Medical Education
View All
August 30th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
August 30th 2025

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory
August 30th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
August 30th 2025

Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

1.5 Credits / Immunization, Infectious Disease, Pulmonology
August 30th 2025

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management

1.5 Credits / Immunology, Pulmonology
August 30th 2025

Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists

1.5 Credits / Pulmonology
August 30th 2025

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

1.5 Credits / Pulmonology, Cardiology, Rare Diseases

More News

FDA approval | Image Credit: Olivier Le Moal - stock.adobe.com
June 26th 2024

FDA Approves Ensifentrine for Maintenance Treatment of Adult Patients With COPD

Brooke McCormick
Today, the FDA approved ensifentrine (Ohtuvayre; Verona Pharma) for the maintenance treatment of moderate to severe chronic obstructive pulmonary disease (COPD) based on the successful phase 3 ENHANCE trials.
Female patient using inhaler | Image Credit: DALU11 - stock.adobe.com
June 12th 2024

High Rates of Inhaler Misuse Found Among Patients With COPD Using Soft Mist Inhalers

Brooke McCormick
Misuse of soft mist inhalers (SMIs) is common among patients with chronic obstructive pulmonary disease (COPD), particularly those with low education levels, higher symptom scores, and a shorter disease duration.
COPD cartoon | Image credit: peterschreiber.media - stock.adobe.com
May 23rd 2024

Dupilumab Improves Pre-, Postbronchodilator Lung Function Measures in Patients With COPD, Type 2 Inflammation

Brooke McCormick
Two abstracts presented at the American Thoracic Society 2024 International Conference analyzed the phase 3 LIBERTY COPD BOREAS trial, finding that dupilumab improves pre- and post-bronchodilator lung function measures in patients with chronic obstructive pulmonary disease (COPD) and type 2 (T2) inflammation.
Doctor holding lung animation | Image Credit: mi_viri - stock.adobe.com
May 20th 2024

Patients With COPD, PRISm at Increased All-Cause, Cause-Specific Mortality Risk

Brooke McCormick
Patients with chronic obstructive pulmonary disease (COPD) and/or preserved ratio impaired spirometry (PRISm) have an increased risk of all-cause and cause-specific mortality, highlighting the need for better understanding of these conditions through increased spirometry data collection.
Heart animation | Image Credit: Siarhei - stock.adobe.com
May 16th 2024

Study: Italian Patients With COPD at High Risk of Severe Cardiovascular Events

Brooke McCormick
Italian patients with chronic obstructive pulmonary disease (COPD) face a significantly increased risk of severe cardiovascular events.
COPD drawing | Image Credit: Ivelin Radkov - stock.adobe.com
May 7th 2024

Low COPD Diagnosis Rate Among Japanese Patients Indicates Underdiagnosis

Brooke McCormick
There is an extremely low rate of chronic obstructive pulmonary disease (COPD) diagnoses in Japan, particularly among patients with airflow obstruction, despite regular respiratory function tests.
drawing of patient with anxiety | Image Credit: tadamichi - stock.adobe.com
May 2nd 2024

Study: Anxiety May Increase Acute Exacerbation Risk for Older Patients With COPD

Brooke McCormick
Older patients with chronic obstructive pulmonary disease (COPD) and anxiety exhibited exacerbated symptoms, increased comorbidities, and frequent acute exacerbations of COPD (AECOPD), emphasizing the need for routine psychiatric screening in COPD management.
Vitamin D | Image Credit: Katsiaryna Hatsak - stock.adobe.com
April 26th 2024

Vitamin D Supplementation Linked to Reduced In-Hospital, ICU Mortality in Patients With COPD

Brooke McCormick
Vitamin D supplementation may decrease in-hospital and intensive care unit (ICU) mortality in patients with chronic obstructive pulmonary disease (COPD), a study found.
COPD | Image Credit: peterschreiber.media - stock.adobe.com
April 24th 2024

Patients With COPD, Muscle Loss Phenotype Face Increased Risk of All-Cause, COPD-Related Death

Brooke McCormick
Patients with chronic obstructive pulmonary disease (COPD) and muscle loss phenotype (MLP) have an elevated risk of all-cause or COPD-related mortality.
COPD exacerbation | Image Credit: RFBSIP - stock.adobe.com
April 22nd 2024

Patient-Reported Outcomes Help to Uncover Frailty Patterns in Those With Acute COPD Exacerbations

Brooke McCormick
Study findings demonstrate the pivotal role of patient-reported outcomes in identifying frailty among individuals experiencing acute exacerbations of chronic obstructive pulmonary disease (COPD).
Jhon Vargas | Image provided by author
April 15th 2024

Contributor: Profit Over People—Medicare Advantage Plans Are Denying Vital NIV Therapy Coverage

Jhon Vargas
A longtime respiratory therapist calls for reform of Medicare Advantage in light of denials of coverage for patients who need non-invasive ventilation.
BMI formula written on notepad | Image Credit: Vitalii Vodolazskyi - stock.adobe.com
April 10th 2024

Study: Decreased BMI Increases Severe Exacerbation, All-Cause Mortality Risk in Patients With COPD

Brooke McCormick
Decreased body mass index (BMI) in patients with chronic obstructive pulmonary disease (COPD) was linked to a higher risk of severe exacerbations and all-cause mortality, emphasizing the importance of monitoring BMI for managing COPD and predicting outcomes.
Inhaler | Image Credit: Andrzej Tokarski - stock.adobe.com
April 3rd 2024

Study: 1 in 6 US Patients With COPD Suffers From Cost-Related Medication Nonadherence

Brooke McCormick
Medication nonadherence among patients with chronic obstructive pulmonary disease (COPD) is associated with increasing COPD symptoms, hospitalizations, morbidity, mortality, and health care expenditures.
COPD animation | Image Credit: peterschreiber.media - stock.adobe.com
March 24th 2024

Dose-Escalation, Low-Dose Regimens May Improve Roflumilast Treatment Adherence in Patients With COPD

Brooke McCormick
This study suggests that dose-escalation or low-dose regimens for roflumilast treatment in patients with chronic obstructive pulmonary disease (COPD) may improve adherence.
man breaking cigarette in half | Image Credit: mbruxelle - stock.adobe.com
March 20th 2024

Smoking Reduction, Cessation Lowers Lung Cancer Risk in Patients With COPD

Brooke McCormick
Reducing or quitting smoking significantly lowered the risk of lung cancer in patients with chronic obstructive pulmonary disease (COPD) who smoked less than 30 pack-years in a recent study.
empty hospital bed | Image Credit: catinsyrup - stock.adobe.com
March 18th 2024

Similar In-Hospital, Long-Term Survival Rates Found Among Male, Female Patients With AECOPD

Brooke McCormick
This study analyzed sex differences among patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD), with findings indicating that female smokers experience worse hospital outcomes despite similar overall survival rates.
Hospital bed | Image Credit: Gorodenkoff - stock.adobe.com
March 14th 2024

Admission Heart Rate Can Be Used as an In-Hospital Mortality Risk Marker in Patients With AECOPD, RF

Brooke McCormick
Results demonstrated a nonlinear relationship between admission heart rate (AHR) and in-hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and respiratory failure (RF).
depressed elderly patient | Image Credit: LIGHTFIELD STUDIOS - stock.adobe.com
March 8th 2024

Frailty, Depression Can Affect Social Support, Self-Management in Older Patients With COPD

Brooke McCormick
Self-management (SM) among older patients with chronic obstructive pulmonary disease (COPD) is moderately low, and frailty and depression may partially mediate the relationship between social support and SM in these patients.
hands cradling model of lungs | Image Credit: SewcreamStudio - stock.adobe.com
March 6th 2024

Study: Oxidative Balance Score Negatively Associated With Frailty in Patients With COPD

Brooke McCormick
In patients with chronic obstructive pulmonary disease (COPD), the higher the oxidative balance score, the lower the frailty risk, especially in women.
flat lining patient in hospital | Image Credit: kinomaster - stock.adobe.com
February 25th 2024

Study: High SII Linked With Increased Respiratory Failure, Death Risk in Patients With COPD

Brooke McCormick
The systemic immune-inflammation index (SII) was found to be a potential predictor of the prognosis of patients with chronic obstructive pulmonary disease (COPD).
3D illustration of heart | Image Credit: yodiyim - stock.adobe.com
February 20th 2024

Patients With COPD Using Triple Therapy Face Increased Cardiovascular Risk, Study Finds

Brooke McCormick
Patients with chronic obstructive pulmonary disease (COPD) on triple therapy face an increased cardiovascular risk.
Diverse group of people exercising | Image Credit: Rawpixel.com - stock.adobe.com
February 15th 2024

Sedentary Patients With COPD Have a Higher Risk of Emergency Department Visits, Study Says

Brooke McCormick
Patients with chronic obstructive pulmonary disease (COPD) and reduced physical activity showed a higher risk of emergency department visits or hospitalizations in a recent study.
woman smoking a cigarette | Image Credit: mitarart - stock.adobe.com
February 6th 2024

Ever-Smokers With COPD Have a Greater Risk of Developing ADHD, Study Says

Brooke McCormick
No causal association with psychiatric disorders was observed in patients with chronic obstructive pulmonary disease (COPD) without a smoking history, while ever-smokers with COPD had a greater risk of developing attention-deficit/hyperactivity disorder (ADHD).
coins | Image Credit: jirsak - stock.adobe.com
February 4th 2024

Study: Patients With COPD and Anxiety or Depression Affected by Higher Clinical, Economic Burdens

Brooke McCormick
Compared with patients with only chronic obstructive pulmonary disease (COPD), patients with COPD and anxiety and/or depression had increased clinical and economic burden.
doctor prescribing inhaled COPD medication | Image Credit: Goffkein - stock.adobe.com
February 1st 2024

Inhaled COPD Medications Associated With Negative Postoperative Outcomes in Patients With Early-Stage NSCLC

Brooke McCormick
Inhaled chronic obstructive pulmonary disease (COPD) medications prescribed before surgery in patients with early-stage non–small cell lung cancer (NSCLC) were associated with both short- and long-term outcomes.
Woman working late at her desk | Image Credit: A.B./peopleimages.com - stock.adobe.com
January 23rd 2024

Long-Term Night Shift Work Associated With Higher COPD Risk

Brooke McCormick
The researchers explained that their findings expanded upon evidence of the harmful respiratory effects of night shifts while also providing valuable evidence for the development of COPD prevention strategies.
Virtual reality | Image Credit: matrosovv - stock.adobe.com
January 21st 2024

VR-Based Pulmonary Rehabilitation More Effective in Patients With COPD, Study Says

Brooke McCormick
Virtual reality (VR) combined with pulmonary rehabilitation was more effective than pulmonary rehabilitation alone in improving the pulmonary function, exercise capacity, and mental health of patients with chronic obstructive pulmonary disease (COPD).
Perelman logo | Image credit : Penn medicine
January 16th 2024

How to Promote Palliative Care? Order by Default, Penn Study Finds

Mary Caffrey
Shifting from an opt-in to an opt-out approach boosted palliative care consults from 16.6% of eligible patients to 43.9%, the investigators found.
COPD | Image Credit: Ivelin Radkov - stock.adobe.com
January 15th 2024

Gabapentinoid Use in COPD Associated With Increased Severe Exacerbation Risk, Study Says

Brooke McCormick
Gabapentinoid use, namely gabapentin and pregabalin, was associated with increased risk for severe chronic obstructive pulmonary disease (COPD) exacerbation in patients with epilepsy, neuropathic pain, and other chronic pain.
white blood cell | Image Credit: SciePro - stock.adobe.com
January 13th 2024

High White Blood Cell Counts Are Associated With Long-Term Acute COPD Exacerbations, Study Says

Brooke McCormick
The study's findings suggest that high baseline white blood cell count, particularly high neutrophil count, was associated with a higher incidence of long-term acute exacerbation of chronic obstructive pulmonary disease (COPD).
<12345678
...
26>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo